Clinical Trial Solutions
Case study CTS001
A unique solution to drastically reduce client exposure to unplanned clinical trial costs associated with unpredictable comparator overages.
As clinical trials are increasingly designed to compare new assets with existing gold standard therapies such as Humira, Keytruda and other high cost reference medicines, the cost of the comparator drug budget is becoming a significant proportion of the total trial budget.
Case study CTS002
A unique offering for the maximum diversity of batch, expiry, and origin conditions for EU clinical trial material
One of our valued clients is a large multinational pharmaceutical company, harnessing new technologies to develop medicines that address unmet medical needs. Their expansive clinical pipeline covers indications where there are already standards of care and multiple lines of potential treatments if the first line is insufficient.
Case study CP0001
EU Specialty Medicine Launch and Distribution: A tailored distribution and commercial support model ensuring effective product launch.
Case study CP0002
Specialty Medicine EU Market Expansion: Developing a unique strategy to continue to successfully drive entry in to new EU markets.
Request Case Study